Skip to main content
. 2003 Nov;185(22):6658–6665. doi: 10.1128/JB.185.22.6658-6665.2003

TABLE 1.

Bacterial strains and plasmids used in this study

Bacterial strain or plasmid Relevant characteristicsa Reference or source
E. coli strains
    DH5a Fλ φ80dlacZΔM15 Δ(lacZYA-argF)U169 recA1 endA1 hsdR17(rK mK+) supE44 thi-1 gyrA relA1 Takara, Kyoto, Japan
    S17-1 thi pro hsdR hsdM+recA [chr::RP4-2-Tc::Mu-Km::Tn7] 22
P. syringae pv. glycinea strains
    race 4 Wild type, Nalr A. Collmer
    race 4-d1 race 4 Δorf1 This study
    race 4-d2 race 4 Δorf2 This study
    race 4-d3 race 4 Δorf3 This study
Plasmids
    pUC18 2.7-kb cloning vector, Apr Takara, Kyoto, Japan
    pUCSac1 1.8-kb SacI-SacI fragment in pUC18, Apr This study
    pUCSac2 13.4-kb SacI-SacI fragment in pUC18, Apr This study
    pUCSal1 1.5-kb SalI-SalI fragment in pUC18, Apr This study
    pCR-blunt II-TOPO 3.5-kb cloning vector for PCR blunt end product, Kmr Invitorgen
    pK18mobsacB Small mobilizable vector, Kmr, sucrose sensitive (sacB) 22
    pM1 2.18-kb chimeric PCR product deleting orf1 cloned into pK18mobsacB at EcoRI site, Kmr This study
    pM2 1.79-kb chimeric PCR product deleting orf2 cloned into pK18mobsacB at EcoRI site, Kmr This study
    pM3 1.69-kb chimeric PCR product deleting orf3 cloned into pK18mobsacB at EcoRI site, Kmr This study
a

Apr, ampicillin resistance; Kmr, kanamycin resistance, Nalr, nalidixic acid resistance.